1. Home
  2. BGLC vs OBLG Comparison

BGLC vs OBLG Comparison

Compare BGLC & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • OBLG
  • Stock Information
  • Founded
  • BGLC 2017
  • OBLG 2000
  • Country
  • BGLC Malaysia
  • OBLG United States
  • Employees
  • BGLC N/A
  • OBLG N/A
  • Industry
  • BGLC Medical Specialities
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • BGLC Health Care
  • OBLG Technology
  • Exchange
  • BGLC Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • BGLC 5.0M
  • OBLG 4.5M
  • IPO Year
  • BGLC N/A
  • OBLG N/A
  • Fundamental
  • Price
  • BGLC $2.71
  • OBLG $3.12
  • Analyst Decision
  • BGLC
  • OBLG
  • Analyst Count
  • BGLC 0
  • OBLG 0
  • Target Price
  • BGLC N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • BGLC 69.9K
  • OBLG 207.1K
  • Earning Date
  • BGLC 08-13-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • BGLC N/A
  • OBLG N/A
  • EPS Growth
  • BGLC N/A
  • OBLG N/A
  • EPS
  • BGLC N/A
  • OBLG N/A
  • Revenue
  • BGLC $9,265,870.00
  • OBLG $2,374,000.00
  • Revenue This Year
  • BGLC N/A
  • OBLG N/A
  • Revenue Next Year
  • BGLC N/A
  • OBLG N/A
  • P/E Ratio
  • BGLC N/A
  • OBLG N/A
  • Revenue Growth
  • BGLC N/A
  • OBLG N/A
  • 52 Week Low
  • BGLC $2.01
  • OBLG $1.91
  • 52 Week High
  • BGLC $8.40
  • OBLG $8.40
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 43.64
  • OBLG 44.15
  • Support Level
  • BGLC $2.60
  • OBLG $3.30
  • Resistance Level
  • BGLC $3.06
  • OBLG $4.13
  • Average True Range (ATR)
  • BGLC 0.21
  • OBLG 0.50
  • MACD
  • BGLC -0.06
  • OBLG -0.10
  • Stochastic Oscillator
  • BGLC 16.27
  • OBLG 18.23

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: